News & Events


Data Provided by Refinitiv. Minimum 15 minutes delayed.

Hero Chart

News Releases

November 22, 2021
FOSTER CITY, Calif. --(BUSINESS WIRE)--Nov. 22, 2021-- Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that it will participate in the following upcoming virtual investor conferences: Piper Sandler 33rd Annual Virtual Healthcare Conference November 30, 2021 Format: Fireside Chat
November 17, 2021
FOSTER CITY, Calif. --(BUSINESS WIRE)--Nov. 17, 2021-- Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leader in rare liver disease, today announced that it has entered into a definitive agreement to sell its Rare Pediatric Disease Priority Review Voucher (“PRV”) for $110 million .